Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study.
van Uden RCAE, Jaspers TCC, Meijer K, van Stralen KJ, Maat B, Khorsand N, van Onzenoort HAW, Swart EL, Huls HJ, Mathôt RAA, Lukens MV, van den Bemt PMLA, Becker ML.
van Uden RCAE, et al. Among authors: swart el.
Thromb Res. 2024 Apr;236:4-13. doi: 10.1016/j.thromres.2024.02.007. Epub 2024 Feb 13.
Thromb Res. 2024.
PMID: 38377636
Free article.